These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 34114685

  • 1. Silencing of the CrkL gene reverses the doxorubicin resistance of K562/ADR cells through regulating PI3K/Akt/MRP1 signaling.
    Yu J, Chen WX, Xie WJ, Chen RW, Lin DQ, You WW, Ye WL, Zhang HQ, Lin DH, Xu JP.
    J Clin Lab Anal; 2021 Aug; 35(8):e23817. PubMed ID: 34114685
    [Abstract] [Full Text] [Related]

  • 2. Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway.
    Chen JR, Jia XH, Wang H, Yi YJ, Wang JY, Li YJ.
    Int J Oncol; 2016 May; 48(5):2063-70. PubMed ID: 26984633
    [Abstract] [Full Text] [Related]

  • 3. Upregulation of miR-181c inhibits chemoresistance by targeting ST8SIA4 in chronic myelocytic leukemia.
    Zhao L, Li Y, Song X, Zhou H, Li N, Miao Y, Jia L.
    Oncotarget; 2016 Sep 13; 7(37):60074-60086. PubMed ID: 27527856
    [Abstract] [Full Text] [Related]

  • 4. Chaetominine reduces MRP1-mediated drug resistance via inhibiting PI3K/Akt/Nrf2 signaling pathway in K562/Adr human leukemia cells.
    Yao J, Wei X, Lu Y.
    Biochem Biophys Res Commun; 2016 May 13; 473(4):867-873. PubMed ID: 27038543
    [Abstract] [Full Text] [Related]

  • 5. Vielanin P enhances the cytotoxicity of doxorubicin via the inhibition of PI3K/Nrf2-stimulated MRP1 expression in MCF-7 and K562 DOX-resistant cell lines.
    Gao HL, Xia YZ, Zhang YL, Yang L, Kong LY.
    Phytomedicine; 2019 May 13; 58():152885. PubMed ID: 31009836
    [Abstract] [Full Text] [Related]

  • 6. Olmutinib Reverses Doxorubicin Resistance in ETS1-Overexpressing Leukemia Cells.
    Zhong J, Zhang J, Yu X, Zhang X, Dian L.
    Med Sci Monit; 2020 Aug 24; 26():e924922. PubMed ID: 32830792
    [Abstract] [Full Text] [Related]

  • 7. Grape seed proanthocyanidin extract reverses multidrug resistance in HL-60/ADR cells via inhibition of the PI3K/Akt signaling pathway.
    Lin KN, Jiang YL, Zhang SG, Huang SY, Li H.
    Biomed Pharmacother; 2020 May 24; 125():109885. PubMed ID: 32007917
    [Abstract] [Full Text] [Related]

  • 8. HOXB4 knockdown reverses multidrug resistance of human myelogenous leukemia K562/ADM cells by downregulating P-gp, MRP1 and BCRP expression via PI3K/Akt signaling pathway.
    Wang H, Jia XH, Chen JR, Yi YJ, Wang JY, Li YJ, Xie SY.
    Int J Oncol; 2016 Dec 24; 49(6):2529-2537. PubMed ID: 27779650
    [Abstract] [Full Text] [Related]

  • 9. Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells.
    Cheng Z, Yang N, Liang W, Yan X, Li L, Pan L.
    Leuk Lymphoma; 2012 Jul 24; 53(7):1383-9. PubMed ID: 22185283
    [Abstract] [Full Text] [Related]

  • 10. Costunolide enhances sensitivity of K562/ADR chronic myeloid leukemia cells to doxorubicin through PI3K/Akt pathway.
    Cai H, Li L, Jiang J, Zhao C, Yang C.
    Phytother Res; 2019 Jun 24; 33(6):1683-1688. PubMed ID: 30937974
    [Abstract] [Full Text] [Related]

  • 11. Linc00518 Contributes to Multidrug Resistance Through Regulating the MiR-199a/MRP1 Axis in Breast Cancer.
    Chang L, Hu Z, Zhou Z, Zhang H.
    Cell Physiol Biochem; 2018 Jun 24; 48(1):16-28. PubMed ID: 30001527
    [Abstract] [Full Text] [Related]

  • 12. The role of long noncoding RNA HOTAIR in the acquired multidrug resistance to imatinib in chronic myeloid leukemia cells.
    Wang H, Li Q, Tang S, Li M, Feng A, Qin L, Liu Z, Wang X.
    Hematology; 2017 May 24; 22(4):208-216. PubMed ID: 27875938
    [Abstract] [Full Text] [Related]

  • 13. Functional screen analysis reveals miR-3142 as central regulator in chemoresistance and proliferation through activation of the PTEN-AKT pathway in CML.
    Zhao L, Shan Y, Liu B, Li Y, Jia L.
    Cell Death Dis; 2017 May 25; 8(5):e2830. PubMed ID: 28542127
    [Abstract] [Full Text] [Related]

  • 14. Effect of resveratrol on doxorubicin resistance in breast neoplasm cells by modulating PI3K/Akt signaling pathway.
    Chen JM, Bai JY, Yang KX.
    IUBMB Life; 2018 Jun 25; 70(6):491-500. PubMed ID: 29637742
    [Abstract] [Full Text] [Related]

  • 15. Involvement of the PI3K/Akt/Nrf2 Signaling Pathway in Resveratrol-Mediated Reversal of Drug Resistance in HL-60/ADR Cells.
    Li Y, Guo Y, Feng Z, Bergan R, Li B, Qin Y, Zhao L, Zhang Z, Shi M.
    Nutr Cancer; 2019 Jun 25; 71(6):1007-1018. PubMed ID: 31032633
    [Abstract] [Full Text] [Related]

  • 16. CXCL12/CXCR4 axis confers adriamycin resistance to human chronic myelogenous leukemia and oroxylin A improves the sensitivity of K562/ADM cells.
    Wang Y, Miao H, Li W, Yao J, Sun Y, Li Z, Zhao L, Guo Q.
    Biochem Pharmacol; 2014 Aug 01; 90(3):212-25. PubMed ID: 24858801
    [Abstract] [Full Text] [Related]

  • 17. Knockdown of microRNA-127 reverses adriamycin resistance via cell cycle arrest and apoptosis sensitization in adriamycin-resistant human glioma cells.
    Feng R, Dong L.
    Int J Clin Exp Pathol; 2015 Aug 01; 8(6):6107-16. PubMed ID: 26261488
    [Abstract] [Full Text] [Related]

  • 18. Overexpression of RSK4 reverses doxorubicin resistance in human breast cancer cells via PI3K/AKT signalling pathway.
    Mei Y, Liao X, Zhu L, Yang H.
    J Biochem; 2020 Jun 01; 167(6):603-611. PubMed ID: 31960922
    [Abstract] [Full Text] [Related]

  • 19. Targeting P-Glycoprotein: Nelfinavir Reverses Adriamycin Resistance in K562/ADR Cells.
    Liu W, Meng Q, Sun Y, Wang C, Huo X, Liu Z, Sun P, Sun H, Ma X, Liu K.
    Cell Physiol Biochem; 2018 Jun 01; 51(4):1616-1631. PubMed ID: 30497065
    [Abstract] [Full Text] [Related]

  • 20. Reversal effect of ST6GAL 1 on multidrug resistance in human leukemia by regulating the PI3K/Akt pathway and the expression of P-gp and MRP1.
    Ma H, Cheng L, Hao K, Li Y, Song X, Zhou H, Jia L.
    PLoS One; 2014 Jun 01; 9(1):e85113. PubMed ID: 24454800
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.